EMPA-REG OUTCOME®: The Endocrinologist’s Point of View
EMPA-REG OUTCOME®: The Endocrinologist’s Point of View
About this item
Full title
Author / Creator
Publisher
United States: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Abstract For many years, it was widely accepted that control of plasma lipids and blood pressure could lower macrovascular risk in patients with type 2 diabetes mellitus (T2DM), while the benefits of lowering plasma glucose were largely limited to improvements in microvascular complications. The EMPA-REG OUTCOME® trial demonstrated - for the first...
Alternative Titles
Full title
EMPA-REG OUTCOME®: The Endocrinologist’s Point of View
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1909238348
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1909238348
Other Identifiers
ISSN
0002-9149
E-ISSN
1879-1913
DOI
10.1016/j.amjcard.2017.05.010
